 |
Acorda Therapeutics
ACOR
|
48.3 |
- |
-24.86 % |
$ 820 K |
USA |
 |
ACADIA Pharmaceuticals
ACAD
|
37.5 |
$ 22.42 |
1.49 % |
$ 3.72 B |
USA |
 |
Adverum Biotechnologies
ADVM
|
222 |
- |
- |
$ 86.2 M |
USA |
 |
I-Mab
IMAB
|
271 |
- |
- |
$ 866 M |
China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 |
- |
- |
$ 40.3 B |
USA |
 |
Alnylam Pharmaceuticals
ALNY
|
58.1 |
$ 326.77 |
2.27 % |
$ 42.8 B |
USA |
 |
Amgen
AMGN
|
81.2 |
$ 349.41 |
2.77 % |
$ 188 B |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
61.7 |
- |
- |
$ 7.46 M |
Israel |
 |
Midatech Pharma plc
MTP
|
204 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
BeiGene, Ltd.
BGNE
|
52.6 |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
Alterity Therapeutics Limited
ATHE
|
16.2 K |
$ 3.85 |
2.39 % |
$ 9.26 B |
Australia |
 |
CymaBay Therapeutics
CBAY
|
182 |
- |
- |
$ 3.45 B |
USA |
 |
Advaxis
ADXS
|
88.1 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
Amphastar Pharmaceuticals
AMPH
|
70.9 |
$ 20.33 |
-1.21 % |
$ 950 M |
USA |
 |
Aquestive Therapeutics
AQST
|
103 |
$ 4.16 |
0.73 % |
$ 445 M |
USA |
 |
Avid Bioservices
CDMO
|
45.6 |
- |
- |
$ 789 M |
USA |
 |
Cidara Therapeutics
CDTX
|
2.26 K |
- |
- |
$ 1.41 B |
USA |
 |
Arcutis Biotherapeutics
ARQT
|
106 |
$ 24.49 |
5.24 % |
$ 3.12 B |
USA |
 |
Checkpoint Therapeutics
CKPT
|
6.83 |
- |
- |
$ 169 M |
USA |
 |
Aeterna Zentaris
AEZS
|
146 |
- |
5.93 % |
$ 314 M |
Canada |
 |
AgeX Therapeutics
AGE
|
186 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Concert Pharmaceuticals
CNCE
|
147 |
- |
- |
$ 401 M |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
216 |
- |
- |
$ 1.01 B |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.114 |
- |
- |
$ 26.5 M |
USA |
 |
Autolus Therapeutics plc
AUTL
|
58.2 |
$ 1.48 |
8.46 % |
$ 394 M |
Britain |
 |
CTI BioPharma Corp.
CTIC
|
52.1 |
- |
- |
$ 1.2 B |
USA |
 |
AIkido Pharma
AIKI
|
17.9 |
- |
1.93 % |
$ 17.4 M |
USA |
 |
Cyclacel Pharmaceuticals
CYCCP
|
3.66 K |
- |
-4.36 % |
$ 27 M |
USA |
 |
Deciphera Pharmaceuticals
DCPH
|
60.8 |
- |
- |
$ 2.18 B |
USA |
 |
Aytu BioScience
AYTU
|
150 |
$ 2.71 |
5.51 % |
$ 17 M |
USA |
 |
Dynavax Technologies Corporation
DVAX
|
56.5 |
- |
- |
$ 2.02 B |
USA |
 |
CureVac N.V.
CVAC
|
13.6 |
- |
- |
$ 867 M |
Germany |